Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Naïve Patients
.
Show all posts
Showing posts with label
Naïve Patients
.
Show all posts
Saturday, February 9, 2019
FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
›
In continuation of my update on ibrutinib The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Foo...
›
Home
View web version
